PRE Prenetics Global Limited - Class A

Prenetics Global Ltd is a diagnostic and genetic testing company. It focuses on bringing health closer to millions of people globally and decentralising healthcare by making the three pillars, namely, Prevention, Diagnostics and Personalized Care, comprehensive and accessible to anyone, anytime and anywhere. It has operations across nine locations, including the United Kingdom, Hong Kong, India, South Africa, and Southeast Asia. The company develops consumer genetic testing and early colorectal cancer screening; provides COVID-19 testing, rapid point of care and at-home diagnostic testing and medical genetic testing.

$4.13  -0.02 (-0.48%)
As of 06/28/2022 14:53:13 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Diagnostics & Research
Index country:  Hong Kong
Country of incorporation:  
IPO date:  05/18/2022
Outstanding shares:  101,265,483
Average volume:  96,716
Market cap:   $425,315,029
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
Sedol:      
Valuation   (See tab for details)
PE ratio:   2.61
PB ratio:   0.06
PS ratio:   0.08
Return on equity:   2.56%
Net income %:   3.25%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy